Skip to main content

Back to guidelines homepage

Morcellation for myomectomy or hysterectomy (Consent Advice No. 13)

Published: 10/10/2019

Please note: This consent advice document should be used as part of the process outlined on our main consent page. The form should be used to help record women’s understanding of the implications of the final agreed procedure and should be used alongside the accompanying patient information Information for you: Morcellation for myomectomy or hysterectomy.

 


 

This paper provides advice for health professionals obtaining consent from women undergoing morcellation for myomectomy or hysterectomy. After careful discussion with the woman, the consent form should be edited under the heading ‘Name of proposed procedure or course of treatment’ to accurately describe the exact procedure to be performed.

The paper follows the structure of Consent Form 1 from the Department of Health and Social Care, England / Welsh Assembly Government / Department of Health, Social Services and Public Safety, Northern Ireland. It should be used as part of the consent process outlined in the Royal College of Obstetricians and Gynaecologists (RCOG) website at rcog.org.uk/consent, and in conjunction with the RCOG Clinical Governance Advice No. 6 Obtaining Valid Consent and Clinical Governance Advice No. 7 Presenting Information on Risk. 

The aim of this advice is to ensure that all women are given consistent and adequate information for consent. It is intended for use together with dedicated patient information Information for you: Morcellation for myomectomy or hysterectomy. At discharge, women should be provided with clear direction to enable them to obtain help if there are unforeseen problems after discharge.

The Consent Advice has been developed by a specialist Morcellation Task and Finish Group as described below.

The Patient Information has been developed by the same specialist Morcellation Task and Finish Group with input also from the RCOG Patient Information Committee and is based directly on this Consent Advice and its evidence base.

The Consent Advice and the Patient Information has been reviewed, before publication, by members of the RCOG Women’s Network and Women’s Voices Involvement Panel and by women and their families across the UK with close experience of this procedure.

It has been agreed that due to the pace of newly emerging evidence around this topic that the consent advice and patient information should be reviewed 1 year on from their publication date.

 


 

Morcellation Task and Finish Group (TFG)

Est. 13 February 2019
 

Brief from the RCOG President:

To review the RCOG Patient Information leaflets on 'Morcellation for laparoscopic hysterectomy’ and ‘Morcellation for laparoscopic myomectomy' in line with the latest evidence and to address any shortfalls in the patient consent document relevant to these procedures.
 

The key aims identified by the TFG on 13 February 2019:  

  1. further review the responses received in relation to the 2018 consultation on the earlier versions – namely:
    • Patient Information: Morcellation for laparoscopic hysterectomy
    • Patient Information: Morcellation for laparoscopic myomectomy
    • Consent advice No. 13 Morcellation for laparoscopic myomectomy or hysterectomy
  2. review the latest literature and evidence available on this topic
  3. revise the patient information and consent advice content (in light of points 1 and 2)
  4. produce revised product(s) to take back out for consultation with stakeholders
  5. present revised product(s) back to the RCOG President with recommendation for publication (subject to successful public consultation)

 

Morcellation TFG Membership

Chair

Professor Hilary Critchley FRCOG

Professor Reproductive Medicine, University of Edinburgh

Deputy Chair

Mr Sanjay Vyas MD FRCOG

President, British Society for Gynaecological Endoscopy

Task & Finish Group Members:

Professor Ian Judson MD, FRCP

The Institute of Cancer Research, British Sarcoma Group & Sarcoma UK

 

Dr Aisha Miah MRCP FRCR

Consultant Clinical Oncologist, Sarcoma Unit, Royal Marsden

British Sarcoma Group & Sarcoma UK

 

Dr Raji Ganesan FRCPath

Sub-speciality Adviser in Gynaecological Pathology

Royal College of Pathologists

 

Professor Nicholas Reed FRCR

Consultant Oncologist, Beatson Clinic, Gartnaval Hospital, Glasgow.

Royal College of Radiologists

 

Dr David Wells FRCR

Consultant Interventional Radiologist

University Hospitals of the North Midlands

British Society of Interventional Radiology & Royal College of Radiologists

 

Dr Tom Holland MRCOG

Consultant O&G, Guys and St Thomas’ NHS Foundation Trust

 

Dr Anwen Gorry MRCOG Consultant O&G

Current Chair of the RCOG Patient Information Committee

 

Dr Geeta Kumar FRCOG Consultant O&G

Immediate previous Chair ofRCOG Patient Information Committee

 

Mr Islam Gameledin MRCOG Clinical Research Fellow, Southmead Hospital, Bristol

 

Operational management and reporting

The TFG was managed internally by the Business Manager for Education, Quality & Projects who reported routinely to relevant RCOG personnel and to the RCOG Clinical Quality Board, which in turn reports to RCOG Council in line with RCOG governance.

 

Patient information

Information about morcellation for myomectomy or hysterectomy